Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Canasa

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

115 API Suppliers, 53 USDMF, 35 CEP/COS, 13 JDMF, 16 EU WC, 10 KDMF, 39 NDC API, 47 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

48 Drugs in Development

48 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

600 FDF Dossiers, 45 FDA Orange Book, 422 Europe, 18 Canada, 48 Australia, 17 South Africa, 50 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

ENEMA;RECTAL - 4GM/60ML, CAPSULE, EXTENDED RELEASE;ORAL - 250MG, CAPSULE, EXTENDED RELEASE;ORAL - 500MG, CAPSULE, DELAYED RELEASE;ORAL - 400MG, SUPPOSITORY;RECTAL - 1GM, TABLET, DELAYED RELEASE;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - 1.2GM, CAPSULE, EXTENDED RELEASE;ORAL - 375MG

RELATED EXCIPIENT COMPANIES

8 Evonik, 3 Rochem International Inc, 1 SPI Pharma, 14 DKSH, 1 Pharm-RX Chemical, 5 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 4 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 31 BASF, 1 CD Formulation, 15 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 1 Finar, 9 Gangwal Chemicals, 12 Ideal Cures, 1 Ingredion Pharma Solutions, 20 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 17 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 13 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

65 Coating Systems & Additives, 47 Fillers, Diluents & Binders, 42 Thickeners and Stabilizers, 39 Controlled & Modified Release, 28 Solubilizers, 28 Disintegrants & Superdisintegrants, 25 Granulation, 23 Direct Compression, 17 Lubricants & Glidants, 16 Topical, 14 Film Formers & Plasticizers, 12 Rheology Modifiers, 11 Taste Masking, 9 Chewable & Orodispersible Aids, 9 Empty Capsules, 8 Co-Processed Excipients, 5 API Stability Enhancers, 5 Emulsifying Agents, 5 Parenteral, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 72 News #PharmaBuzz

GLOBAL SALES INFORMATION

41 US Medicaid Prescriptions, 155 Regulatory FDF Prices, 37 Annual Reports

MARKET PLACE

26 APIs, 14 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 10 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 22 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Axplora	Germany	PharmaZell GmbH Raubling DE	CEP 2003-203 - Rev 03	Mesalazine	2023-11-08	Valid	Chemical		1699
29/11/2025	Zhejiang Hengkang Pharmaceutical	China	ZHEJIANG HENGKANG PHARMACEUTICAL CO., LTD. Sanmen CN	R0-CEP 2021-400 - Rev 00	Mesalazine, Pubagang site	2021-12-17	Valid	Chemical		1699

Canasa

Canasa

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

115 API Suppliers

53 USDMF

35 CEP/COS

13 JDMF

16 EU WC

10 KDMF

39 NDC API

47 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

48 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

600 FDF Dossiers

45 FDA Orange Book

422 Europe

18 Canada

48 Australia

17 South Africa

50 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

ENEMA;RECTAL - 4GM/60ML

CAPSULE, EXTENDED RELEASE;ORAL - 250MG

CAPSULE, EXTENDED RELEASE;ORAL - 500MG

CAPSULE, DELAYED RELEASE;ORAL - 400MG

SUPPOSITORY;RECTAL - 1GM

TABLET, DELAYED RELEASE;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, DELAYED RELEASE;ORAL - 1.2GM

CAPSULE, EXTENDED RELEASE;ORAL - 375MG

RELATED EXCIPIENT COMPANIES

8 Evonik

3 Rochem International Inc

1 SPI Pharma

14 DKSH

1 Pharm-RX Chemical

5 Boai NKY Pharmaceuticals Ltd

4 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

2 Kirsch Pharma

4 ACG Worldwide

3 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

31 BASF

1 CD Formulation

15 Corel Pharma Chem

5 DFE Pharma

3 Doshion Polyscience

1 Esteem Industries

1 Finar

9 Gangwal Chemicals

12 Ideal Cures

1 Ingredion Pharma Solutions

20 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

2 Lubrizol Life Science Health

17 Microlex e.U

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

4 Pharmatrans-Sanaq

3 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

13 Roquette

6 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

TABLET, DELAYED RELEASE;ORAL - 800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons